Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Sarcoidosis: full-pipeline trial registry
12 of 22 indexed Sarcoidosis trials are currently recruiting.
Corpus placement: #756 of 28,707 conditions by registered trial count.
22 US clinical trials · 12 currently recruiting · #756 of 28,707 conditions by registered trial count
Sarcoidosis: 22 US clinical trials tracked, 12 recruiting.
Sarcoidosis is the subject of 22 registered US clinical trials on ClinicalTrials.gov, 12 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is University of Kansas Medical Center, running 2 of these trials.
Enrollment posture brief
Registry condition sarcoidosis
OPEN 12 | RECR 55% | LATE 4 | EARLY 3 | RANK #756 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Advanced Ovarian Carcinoma (55% recruiting · 11 trials)
Sarcoidosis lists 12 open slots (55% of 22 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Sarcoidosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Sarcoidosis is recruiting above its size-band peers.
12 of 22 indexed trials (54.5%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Sarcoidosis trials is spread across many organizations.
University of Kansas Medical Center accounts for 2 of 22 trials (9.1%). 19 distinct sponsors appear on at least one study for this condition label.
-
Typical Sarcoidosis enrolment sits around 125 participants.
Median target enrolment is 125 among the 22 trials that report a genuine target (sentinel values excluded). 9 of those (40.9%) plan for fewer than 100 participants.
-
Sarcoidosis splits between interventional and observational designs.
10 interventional and 12 observational studies make up this index (45.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
22 total, page 1 of 1
Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis
Duke University
NCT01745237
Foundation for Sarcoidosis Research Advanced Cures Registry (FSR-SARC Registry)
Foundation for Sarcoidosis Research
NCT06234384
Cardiovascular Multimodality Imaging Study
Montefiore Medical Center
NCT06610019
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
University of Chicago
NCT00470327
Interstitial Lung Disease Research Unit Biobank
University of Kansas Medical Center
NCT05392881
Cardiac Sarcoidosis Randomized Trial
Ottawa Heart Institute Research Corporation
NCT03593759
Quantification & Classification of Inflammatory Cells in Uveitis Using OCT
Oregon Health and Science University
NCT07065747
Cell Free DNA in Cardiac Sarcoidosis
Nabeel Hamzeh
NCT03858777
Virtual Patient Groups for Sarcoidosis Associated Fatigue
The Cleveland Clinic
NCT07073963
Vitamin D Homeostasis in Sarcoidosis
University of Texas Southwestern Medical Center
NCT03621553
Full-Field Optical Coherence Tomography (FFOCT) for Evaluation of Bronchoscopic Small Biopsy Specimens
Johns Hopkins University
NCT05171478
Use of CXCL9 as a Biomarker of Acthar Efficacy
University of California, San Francisco
NCT02523092
Medication Adherence in Patients With Sarcoidosis
Johns Hopkins University
NCT05438095
Identifying Shared Genetic Susceptibility Regions in Chronic Beryllium Disease and Sarcoidosis
National Jewish Health
NCT00560989
CZI Rare As One: Co-designing an App and Wearable Based Compass for Rare Diseases
4YouandMe
NCT06907953
Association Between Cancer and Sarcoidosis
University of Miami
NCT03844698
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
University of North Carolina, Chapel Hill
NCT01615484
Inhaled Iloprost for Sarcoidosis-associated Pulmonary Hypertension
University of Cincinnati
NCT00403650
Evaluation of MyoStrain™ in Clinical Practice
University of Kansas Medical Center
NCT03825224
Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension
Medical University of South Carolina
NCT00851929
Optimizing Acquisition Parameters and Interpretive Methods of FDG-PET/CT With Rb-82
Yale University
NCT03048097
Janus Kinase Inhibition in Sarcoidosis
Yale University
NCT05696795
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
| Phase 3 | 1 |
| Phase 4 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Sarcoidosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Sarcoidosis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Sarcoidosis page
22 registered trials, 12 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 12 Sarcoidosis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Kansas Medical Center sponsors the most Sarcoidosis trials on record, review their full trial history before evaluating a specific study. See University of Kansas Medical Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Sarcoidosis condition card totals 22 registered trials; most-linked intervention Observational - no intervention; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.